Literature DB >> 21993716

Gastric infection by Helicobacter pylori.

George Sachs1, David R Scott, Yi Wen.   

Abstract

Helicobacter pylori infects half of the world's population and plays a causal role in ulcer disease and gastric cancer. This pathogenic neutralophile uniquely colonizes the acidic gastric milieu through the process of acid acclimation. Acid acclimation is the ability of the organism to maintain periplasmic pH near neutrality in an acidic environment to prevent a fall in cytoplasmic pH in order to maintain viability and growth in acid. Recently, due to an increase in antibiotic resistance, the rate of H. pylori eradication has fallen below 80% generating renewed interest in novel eradication regimens and targets. In this article, we review the gastric biology of H. pylori and acid acclimation, various detection procedures, antibiotic resistance and the role that gastric acidity plays in the susceptibility of the organism to antibiotics currently in use and propose several novel drug targets that would promote eradication in the absence of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993716      PMCID: PMC4531091          DOI: 10.1007/s11894-011-0226-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  45 in total

1.  A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH.

Authors:  G M Young; D Amid; V L Miller
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster.

Authors:  Petra Voland; David L Weeks; Elizabeth A Marcus; Christian Prinz; George Sachs; David Scott
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09-04       Impact factor: 4.052

Review 4.  Helicobacter pylori and gastritis: Untangling a complex relationship 27 years on.

Authors:  Victoria P Y Tan; Benjamin C Y Wong
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

5.  Control of acid resistance in Escherichia coli.

Authors:  M P Castanie-Cornet; T A Penfound; D Smith; J F Elliott; J W Foster
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

6.  Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface.

Authors:  David R Scott; Elizabeth A Marcus; Yi Wen; Jane Oh; George Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

Review 7.  Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.

Authors:  Sheila M Wilhelm; Jennifer L Johnson; Pramodini B Kale-Pradhan
Journal:  Ann Pharmacother       Date:  2011-06-21       Impact factor: 3.154

8.  Characterization of the ArsRS regulon of Helicobacter pylori, involved in acid adaptation.

Authors:  Michael Pflock; Nadja Finsterer; Biju Joseph; Hans Mollenkopf; Thomas F Meyer; Dagmar Beier
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

Review 9.  Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori.

Authors:  T Furuta; N Shirai; K Ohashi; T Ishizaki
Journal:  Methods Find Exp Clin Pharmacol       Date:  2003-03

10.  Expression of UreI is required for intragastric transit and colonization of gerbil gastric mucosa by Helicobacter pylori.

Authors:  Marina Mollenhauer-Rektorschek; Guido Hanauer; George Sachs; Klaus Melchers
Journal:  Res Microbiol       Date:  2002-12       Impact factor: 3.992

View more
  29 in total

1.  The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.

Authors:  Raksawan Deenonpoe; Chariya Chomvarin; Chawalit Pairojkul; Yaowalux Chamgramol; Alex Loukas; Paul J Brindley; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2015

2.  Characterization of Helicobacter pylori bacteriophage KHP30.

Authors:  Jumpei Uchiyama; Hiroaki Takeuchi; Shin-ichiro Kato; Keiji Gamoh; Iyo Takemura-Uchiyama; Takako Ujihara; Masanori Daibata; Shigenobu Matsuzaki
Journal:  Appl Environ Microbiol       Date:  2013-03-08       Impact factor: 4.792

3.  A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori.

Authors:  Hong Wu; Takashi Nakano; Yuji Matsuzaki; Yukimasa Ooi; Takehiro Kohno; Sonoko Ishihara; Kouichi Sano
Journal:  Med Mol Morphol       Date:  2014-01-14       Impact factor: 2.309

4.  Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study.

Authors:  M Campanale; E Nucera; V Ojetti; V Cesario; T A Di Rienzo; G D'Angelo; S Pecere; F Barbaro; G Gigante; T De Pasquale; A Rizzi; G Cammarota; D Schiavino; F Franceschi; A Gasbarrini
Journal:  Dig Dis Sci       Date:  2014-03-05       Impact factor: 3.199

5.  Seroepidemiology of Helicobacter pylori infection in elderly people in the Beijing region, China.

Authors:  Mei Zhang; Ying-Zhi Zhou; Xiao-Ying Li; Zhe Tang; Hong-Ming Zhu; Yan Yang; Jagadish K Chhetri
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

6.  Helicobacter pylori Eradication Using Laser Endoscope and Methylene Blue.

Authors:  Kouji Ogasawara; Susumu Nakajima; Hiroshi Sato; Tadashi Sasaki
Journal:  Laser Ther       Date:  2020-07-17

7.  Is the nickel-dependent urease complex of Cryptococcus the pathogen's Achilles' heel?

Authors:  Carl A Morrow; James A Fraser
Journal:  MBio       Date:  2013-06-25       Impact factor: 7.867

8.  Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.

Authors:  Hidetaka Okubo; Junichi Akiyama; Masao Kobayakawa; Megumi Kawazoe; Saori Mishima; Yusuke Takasaki; Naoyoshi Nagata; Takayuki Shimada; Chizu Yokoi; Shiori Komori; Kana Kimura; Yuya Hisada; Eri Iwata; Kazuhiro Watanabe; Naohiro Yanagisawa; Sho Shiroma; Akira Shimomura; Koki Okahara; Hourin Cho; Naomi Uemura
Journal:  J Gastroenterol       Date:  2020-09-15       Impact factor: 7.527

9.  Helicobacter pylori Eradication Therapy: Current Availabilities.

Authors:  M Gasparetto; M Pescarin; G Guariso
Journal:  ISRN Gastroenterol       Date:  2012-07-29

10.  Seroepidemiology of Helicobacter pylori Infection in Tepehuanos Aged 15 Years and Older in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel
Journal:  J Pathog       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.